The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.25
Bid: 19.00
Ask: 19.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.632%)
Open: 19.25
High: 19.25
Low: 19.25
Prev. Close: 19.25
TEAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (TEAM plc)

7 Apr 2021 18:14

RNS Number : 7446U
Team PLC
07 April 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TEAM plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and

beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TEAM plc (OFFEROR)

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/04/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

(2) Cash-settled derivatives:

Nil

Nil

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

 

 

 

 

 

 

 

 

 

 

Name

Number of ordinary shares held

% of voting share capital

Mark Clubb

3,353,083

20.25

Michael Gray

22,727

0.14

Philip Taylor

17,045

0.10

David Turnbull

17,045

0.10

Total

3,409,900

20.59

 

 

 

 

 

 

 

Individual

Number of TEAM plc ordinary shares beneficially owned

% of TEAM plc issued ordinary share capital

Role

Giles Fitzpatrick

284,090

1.72

Partner

Ian Hannam

284,090

1.72

Founding Partner

Rupert Fane

56,818

0.34

Partner

James Ward

51,136

0.31

Former CFO

Richard Clarke

34,090

0.21

Special Advisor

Andrew Chubb

28,409

0.17

Partner

Matthew Hasson

28,409

0.17

Partner

Total

767,042

4.63

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

(c) Attachments

 

 

 

Date of disclosure:

7 April 2021

Contact name:

Matthew Moore

Telephone number*:

0153 4877 210 (TEAM plc)

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at w ww.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUBRBRABUSRAR
Date   Source Headline
17th Apr 20244:00 pmRNSResult of AGM and Issue of New Shares
12th Apr 20247:00 amRNSResult of WRAP Retail Offer
9th Apr 20247:00 amRNSNotice of Investor Presentation
5th Apr 202411:15 amRNSDirector/PDMR Shareholding
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:25 pmRNSResult of Subscription
28th Mar 20247:02 amRNSWrap Retail Offer
28th Mar 20247:01 amRNSPlacing, Subscription and Wrap Retail Offer
28th Mar 20247:00 amRNSFinal Results
29th Feb 20244:00 pmRNSChange of Adviser
27th Dec 20237:00 amRNSAcquisition of HBFS
12th Dec 20237:00 amRNSAcquisition of Neba Businesses
9th Nov 202312:20 pmRNSHolding(s) in Company
8th Nov 20239:50 amRNSHolding(s) in Company
7th Nov 20234:40 pmRNSHolding(s) in Company
27th Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Sep 20237:00 amRNSLoan Note
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20237:02 amRNSAcquisition
1st Jun 20237:01 amRNSAcquisition
1st Jun 20237:00 amRNSHalf-year Report
31st Jan 20234:00 pmRNSResult of AGM
12th Jan 202311:30 amRNSNotice of AGM
11th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSFinal Results
26th Oct 20222:18 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSChange of Adviser
9th Aug 20224:45 pmRNSDirector/PDMR Shareholding
8th Aug 20229:03 amRNSAcquisition
4th Aug 20223:35 pmRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSCompletion of Acquisition
1st Jul 20221:45 pmRNSDirector/PDMR Shareholding
23rd Jun 20221:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:10 pmRNSResult of AGM
22nd Jun 20227:00 amRNSHalf-year Report
7th Jun 20229:15 amRNSNotice of AGM
16th May 20225:30 pmRNSDirector/PDMR Shareholding
16th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20227:05 amRNSChanges to Management Incentive Plan
12th May 20227:00 amRNSProposed Acquisition, Subscription &Trading Update
23rd Feb 20227:00 amRNSIssue of Equity
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:01 amRNSFinal Results
1st Dec 20217:00 amRNSAcquisition
5th Oct 202110:30 amRNSChange of Registered Office
26th Aug 20211:10 pmRNSDirector/PDMR Shareholding
10th Aug 202110:45 amRNSDirector/PDMR Shareholding
5th Jul 202111:05 amRNSDirector/PDMR Shareholding
5th Jul 20217:00 amRNSAcquisition of JCAP Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.